Prof. Yao Yang (姚阳) — Bone & Soft Tissue Sarcoma | Shanghai Sixth People's Hospital
For international patients facing a diagnosis of bone sarcoma, soft tissue sarcoma, or cancer-related bone metastasis, finding a physician with both deep subspecialty expertise and a track record of building an entire clinical discipline is rare. Prof. Yao Yang (姚阳) is precisely that physician — a founding pioneer of medical oncology for bone and soft tissue tumors in China, and the architect of one of Shanghai's most specialized sarcoma programs.
Sarcomas account for fewer than 1% of all adult cancers globally, yet they carry disproportionate complexity: dozens of histological subtypes, variable chemosensitivity, and a frequent need for limb-salvage surgery coordinated with systemic treatment. In this landscape, Prof. Yao Yang's career-long focus on this exact disease group makes him one of the most experienced sarcoma medical oncologists in China.
Specialty Focus
- Bone sarcomas: osteosarcoma, Ewing sarcoma, chondrosarcoma, spindle cell sarcoma
- Soft tissue sarcomas: synovial sarcoma, liposarcoma, leiomyosarcoma, undifferentiated pleomorphic sarcoma (UPS), GIST, rhabdomyosarcoma
- Malignant bone metastasis from breast, lung, prostate, kidney, and thyroid cancers
- Systemic chemotherapy, targeted therapy, and immunotherapy for musculoskeletal tumors
- Multidisciplinary coordination with orthopedic oncology surgery and interventional radiology
Academic & Clinical Titles
- Chief Physician & Professor, Department of Medical Oncology, Shanghai Sixth People's Hospital
- Discipline Leader (学科带头人), Bone & Soft Tissue Tumor Oncology
- Founder, Department of Medical Oncology, Shanghai Sixth People's Hospital
- Affiliated with Shanghai Jiao Tong University School of Medicine
A Pioneer Who Built a Discipline
Bone and soft tissue sarcomas are among the rarest and most technically demanding cancers to treat. In China, the medical oncology subspecialty for these tumors barely existed as a formal discipline before Prof. Yao Yang's work. He is widely recognized as one of the founding figures who established the academic and clinical framework for bone and soft tissue tumor internal medicine in China — a contribution that has shaped how sarcoma patients across the country are treated today.
As the founder of the Medical Oncology Department at Shanghai Sixth People's Hospital, Prof. Yao built a program from the ground up, integrating systemic chemotherapy, targeted therapy, and multidisciplinary coordination for sarcoma patients. This was not simply an administrative achievement — it required defining treatment protocols, training a generation of oncologists, and establishing referral pathways that now serve patients from across China and internationally.
Shanghai Sixth People's Hospital is nationally recognized for its orthopedic and musculoskeletal expertise, consistently ranked among China's top institutions for bone tumor surgery. Prof. Yao Yang's medical oncology program sits at the center of this ecosystem, providing the systemic treatment backbone that complements the hospital's surgical excellence.
Clinical Philosophy: Individualized, Evidence-Based Sarcoma Care
Prof. Yao Yang's clinical philosophy centers on the recognition that sarcomas are not a single disease but a heterogeneous group of tumors — each subtype with its own biology, chemosensitivity profile, and optimal treatment sequence. His approach is built on three pillars:
1. Accurate Pathological Diagnosis First
Effective sarcoma treatment begins with precise histological and molecular classification. Prof. Yao's team works closely with pathologists to ensure that subtype-specific diagnoses — including molecular markers relevant to targeted therapy eligibility — are established before treatment decisions are made. For international patients who arrive with prior biopsies, re-review by Shanghai Sixth People's pathology team is often recommended.
2. Multidisciplinary Treatment Planning
Sarcoma management rarely involves a single specialty. Prof. Yao Yang coordinates closely with orthopedic oncology surgeons, radiation oncologists, interventional radiologists, and rehabilitation specialists. For patients with limb sarcomas, the goal is always to evaluate limb-salvage options before considering amputation — a decision that requires surgical and oncological expertise working in concert.
3. Systemic Therapy Optimization
From neoadjuvant chemotherapy designed to shrink tumors before surgery, to adjuvant regimens that reduce recurrence risk, to palliative systemic therapy for metastatic disease, Prof. Yao Yang's team tailors treatment intensity and sequencing to each patient's disease stage, performance status, and treatment goals. Where applicable, targeted agents and immunotherapy are incorporated based on molecular profiling.
Bone Metastasis: A Critical Subspecialty
Beyond primary sarcomas, Prof. Yao Yang has extensive expertise in malignant bone metastasis — a complication that affects a significant proportion of patients with advanced breast, lung, prostate, kidney, and thyroid cancers. Bone metastases can cause severe pain, pathological fractures, spinal cord compression, and hypercalcemia, all of which require prompt, coordinated management.
Effective treatment of bone metastasis requires both oncological precision — selecting the right systemic agents, bone-modifying drugs, and local therapies — and close orthopedic collaboration to assess structural integrity and fracture risk. Shanghai Sixth People's Hospital's combined orthopedic and oncology expertise makes it one of the most appropriate institutions in China for patients dealing with this complication.
For international patients whose primary oncologist has identified bone metastasis as a concern, Prof. Yao Yang's team can provide a second opinion on systemic management strategy, bone-modifying agent selection, and the role of local interventions such as radiation or surgical stabilization.
What International Patients Should Know
Sarcoma is a disease where subspecialty volume matters. Studies consistently show that outcomes for sarcoma patients are significantly better at high-volume centers with dedicated multidisciplinary teams. For patients in countries where sarcoma expertise is limited or fragmented, seeking evaluation at a specialized center like Shanghai Sixth People's Hospital can meaningfully change the treatment plan — and in some cases, the prognosis.
Common scenarios where international patients seek Prof. Yao Yang's expertise include:
- A new sarcoma diagnosis where the patient wants a second opinion before starting treatment
- Recurrent or refractory sarcoma after first-line chemotherapy, where options in the home country are limited
- Rare sarcoma subtypes (e.g., epithelioid sarcoma, alveolar soft part sarcoma) where local oncologists have limited experience
- Bone metastasis management in the context of an advanced solid tumor
- Patients seeking access to clinical trials or newer agents not yet available in their home country
How CMCS Connects You with Prof. Yao Yang
China Medical Concierge Shanghai (CMCS) facilitates access to Prof. Yao Yang for international patients who require expert evaluation for bone sarcoma, soft tissue sarcoma, or bone metastasis. Our team manages the full coordination process — from remote case review and medical record translation to appointment scheduling, interpretation, and in-hospital support.
To begin, patients or their families are encouraged to share available medical records, imaging reports (CT, MRI, PET-CT), pathology results, and prior treatment summaries. Prof. Yao Yang's team can conduct an initial remote assessment before any travel to Shanghai is required, allowing patients to make an informed decision about whether an in-person consultation is warranted.
CMCS provides end-to-end support throughout the process, including:
- Medical record translation (English, Arabic, French, and other languages)
- Remote pre-consultation case review
- Appointment coordination with Prof. Yao Yang's clinic
- On-site interpretation during consultations and procedures
- Coordination with surgical, radiology, and pathology teams as needed
- Post-consultation summary and follow-up support
Contact CMCS to Connect with Prof. Yao Yang
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
CMCS – China Medical Concierge Shanghai connects international patients with Shanghai's leading specialists. We are a health management company, not a hospital. All clinical decisions are made by the treating physician.
0 commenti